Cargando…

Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review

OBJECTIVES: The COVID-19 pandemic has had a major impact on our society, with drastic policy restrictions being implemented to contain the spread of the severe acute respiratory syndrome coronavirus 2. This study aimed to provide an overview of the available evidence on the cost-effectiveness of var...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandepitte, Sophie, Alleman, Tijs, Nopens, Ingmar, Baetens, Jan, Coenen, Samuel, De Smedt, Delphine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481648/
https://www.ncbi.nlm.nih.gov/pubmed/34711355
http://dx.doi.org/10.1016/j.jval.2021.05.013
_version_ 1784576722369249280
author Vandepitte, Sophie
Alleman, Tijs
Nopens, Ingmar
Baetens, Jan
Coenen, Samuel
De Smedt, Delphine
author_facet Vandepitte, Sophie
Alleman, Tijs
Nopens, Ingmar
Baetens, Jan
Coenen, Samuel
De Smedt, Delphine
author_sort Vandepitte, Sophie
collection PubMed
description OBJECTIVES: The COVID-19 pandemic has had a major impact on our society, with drastic policy restrictions being implemented to contain the spread of the severe acute respiratory syndrome coronavirus 2. This study aimed to provide an overview of the available evidence on the cost-effectiveness of various coronavirus disease 2019 policy measures. METHODS: A systematic literature search was conducted in PubMed, Embase, and Web of Science. Health economic evaluations considering both costs and outcomes were included. Their quality was comprehensively assessed using the Consensus Health Economic Criteria checklist. Next, the quality of the epidemiological models was evaluated. RESULTS: A total of 3688 articles were identified (March 2021), of which 23 were included. The studies were heterogeneous with regard to methodological quality, contextual factors, strategies’ content, adopted perspective, applied models, and outcomes used. Overall, testing/screening, social distancing, personal protective equipment, quarantine/isolation, and hygienic measures were found to be cost-effective. Furthermore, the most optimal choice and combination of strategies depended on the reproduction number and context. With a rising reproduction number, extending the testing strategy and early implementation of combined multiple restriction measures are most efficient. CONCLUSIONS: The quality assessment highlighted numerous flaws and limitations in the study approaches; hence, their results should be interpreted with caution because the specific context (country, target group, etc) is a key driver for cost-effectiveness. Finally, including a societal perspective in future evaluations is key because this pandemic has an indirect impact on the onset and treatment of other conditions and on our global economy.
format Online
Article
Text
id pubmed-8481648
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84816482021-09-30 Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review Vandepitte, Sophie Alleman, Tijs Nopens, Ingmar Baetens, Jan Coenen, Samuel De Smedt, Delphine Value Health Themed Section: COVID-19 OBJECTIVES: The COVID-19 pandemic has had a major impact on our society, with drastic policy restrictions being implemented to contain the spread of the severe acute respiratory syndrome coronavirus 2. This study aimed to provide an overview of the available evidence on the cost-effectiveness of various coronavirus disease 2019 policy measures. METHODS: A systematic literature search was conducted in PubMed, Embase, and Web of Science. Health economic evaluations considering both costs and outcomes were included. Their quality was comprehensively assessed using the Consensus Health Economic Criteria checklist. Next, the quality of the epidemiological models was evaluated. RESULTS: A total of 3688 articles were identified (March 2021), of which 23 were included. The studies were heterogeneous with regard to methodological quality, contextual factors, strategies’ content, adopted perspective, applied models, and outcomes used. Overall, testing/screening, social distancing, personal protective equipment, quarantine/isolation, and hygienic measures were found to be cost-effective. Furthermore, the most optimal choice and combination of strategies depended on the reproduction number and context. With a rising reproduction number, extending the testing strategy and early implementation of combined multiple restriction measures are most efficient. CONCLUSIONS: The quality assessment highlighted numerous flaws and limitations in the study approaches; hence, their results should be interpreted with caution because the specific context (country, target group, etc) is a key driver for cost-effectiveness. Finally, including a societal perspective in future evaluations is key because this pandemic has an indirect impact on the onset and treatment of other conditions and on our global economy. ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021-11 2021-09-30 /pmc/articles/PMC8481648/ /pubmed/34711355 http://dx.doi.org/10.1016/j.jval.2021.05.013 Text en © 2021 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Themed Section: COVID-19
Vandepitte, Sophie
Alleman, Tijs
Nopens, Ingmar
Baetens, Jan
Coenen, Samuel
De Smedt, Delphine
Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
title Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
title_full Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
title_fullStr Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
title_full_unstemmed Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
title_short Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
title_sort cost-effectiveness of covid-19 policy measures: a systematic review
topic Themed Section: COVID-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481648/
https://www.ncbi.nlm.nih.gov/pubmed/34711355
http://dx.doi.org/10.1016/j.jval.2021.05.013
work_keys_str_mv AT vandepittesophie costeffectivenessofcovid19policymeasuresasystematicreview
AT allemantijs costeffectivenessofcovid19policymeasuresasystematicreview
AT nopensingmar costeffectivenessofcovid19policymeasuresasystematicreview
AT baetensjan costeffectivenessofcovid19policymeasuresasystematicreview
AT coenensamuel costeffectivenessofcovid19policymeasuresasystematicreview
AT desmedtdelphine costeffectivenessofcovid19policymeasuresasystematicreview